Click for best price
Sexual Dysfunction Drugs Market Size, Share 2022
Market Analysis and Insights: Global Sexual Dysfunction Drugs Market
The global Sexual Dysfunction Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Sexual Dysfunction Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Sexual Dysfunction Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Sexual Dysfunction Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Sexual Dysfunction Drugs market.
Global Sexual Dysfunction Drugs Scope and Market Size
Sexual Dysfunction Drugs market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Sexual Dysfunction Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Sexual Dysfunction Drugs market size by players, by Type and by User, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type
Oral Therapy
Intracavernosal Therapy
Hormonal Therapy
Transurethral Therapy
Segment by User
Male
Female
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Pfizer
GlaxoSmithKline
Merck
Eli Lilly
AbbVie
Bayer
Teva Pharmaceutical Industries
Takeda
Apricus Biosciences
Emotional Brain
Ivix LLX
Leadiant Biosciences
NexMed
S1 Biopharma
Vietstar Biomedical Research
The information for each competitor/Company Profile includes:
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
The content of the study subjects includes a total of 15 chapters:
Chapter 1, describes Sexual Dysfunction Drugs product scope, market overview, market opportunities, market driving force, and market risks.
Chapter 2, profiles the top manufacturers of Sexual Dysfunction Drugs, with price, sales, revenue, and global market share of Sexual Dysfunction Drugs from 2019 to 2022.
Chapter 3, the Sexual Dysfunction Drugs competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Sexual Dysfunction Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.
Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Sexual Dysfunction Drugs market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Sexual Dysfunction Drugs.
Chapter 13, 14, and 15, to describe Sexual Dysfunction Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Key Indicators Analysed:
- Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
- Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
- Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
- Opportunities and Drivers: Identifying the Growing Demands and New Technology
- Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Reasons to Purchase this Report:
- Estimates 2022-2027 2021-2025 Sexual Dysfunction Drugs Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
- 1-year analyst support, along with the data support in excel format.
Research Methodology:
The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.
| Report Attributes |
Report Details |
| Report Title |
Global and United States Sexual Dysfunction Drugs Market Report & Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
110 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Study Coverage
1.1 Sexual Dysfunction Drugs Product Introduction
1.2 Global Sexual Dysfunction Drugs Outlook 2017 VS 2022 VS 2028
1.2.1 Global Sexual Dysfunction Drugs Sales in US$ Million for the Year 2017-2028
1.2.2 Global Sexual Dysfunction Drugs Sales in Volume for the Year 2017-2028
1.3 United States Sexual Dysfunction Drugs Outlook 2017 VS 2022 VS 2028
1.3.1 United States Sexual Dysfunction Drugs Sales in US$ Million for the Year 2017-2028
1.3.2 United States Sexual Dysfunction Drugs Sales in Volume for the Year 2017-2028
1.4 Sexual Dysfunction Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Sexual Dysfunction Drugs in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Sexual Dysfunction Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Sexual Dysfunction Drugs Market Dynamics
1.5.1 Sexual Dysfunction Drugs Industry Trends
1.5.2 Sexual Dysfunction Drugs Market Drivers
1.5.3 Sexual Dysfunction Drugs Market Challenges
1.5.4 Sexual Dysfunction Drugs Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Sexual Dysfunction Drugs Market Segment by Type
2.1.1 Oral Therapy
2.1.2 Intracavernosal Therapy
2.1.3 Hormonal Therapy
2.1.4 Transurethral Therapy
2.2 Global Sexual Dysfunction Drugs Market Size by Type
2.2.1 Global Sexual Dysfunction Drugs Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Sexual Dysfunction Drugs Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Sexual Dysfunction Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Sexual Dysfunction Drugs Market Size by Type
2.3.1 United States Sexual Dysfunction Drugs Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Sexual Dysfunction Drugs Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Sexual Dysfunction Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by User
3.1 Sexual Dysfunction Drugs Market Segment by User
3.1.1 Male
3.1.2 Female
3.2 Global Sexual Dysfunction Drugs Market Size by User
3.2.1 Global Sexual Dysfunction Drugs Sales in Value, by User (2017, 2022 & 2028)
3.2.2 Global Sexual Dysfunction Drugs Sales in Volume, by User (2017, 2022 & 2028)
3.3.3 Global Sexual Dysfunction Drugs Average Selling Price (ASP) by User (2017, 2022 & 2028)
3.3 United States Sexual Dysfunction Drugs Market Size by User
3.3.1 United States Sexual Dysfunction Drugs Sales in Value, by User (2017, 2022 & 2028)
3.3.2 United States Sexual Dysfunction Drugs Sales in Volume, by User (2017, 2022 & 2028)
3.3.3 United States Sexual Dysfunction Drugs Average Selling Price (ASP) by User (2017, 2022 & 2028)
4 Global Sexual Dysfunction Drugs Competitor Landscape by Company
4.1 Global Sexual Dysfunction Drugs Market Size by Company
4.1.1 Top Global Sexual Dysfunction Drugs Manufacturers Ranked by Revenue (2021)
4.1.2 Global Sexual Dysfunction Drugs Revenue by Manufacturer (2017-2022)
4.1.3 Global Sexual Dysfunction Drugs Sales by Manufacturer (2017-2022)
4.1.4 Global Sexual Dysfunction Drugs Price by Manufacturer (2017-2022)
4.2 Global Sexual Dysfunction Drugs Concentration Ratio (CR)
4.2.1 Sexual Dysfunction Drugs Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Sexual Dysfunction Drugs in 2021
4.2.3 Global Sexual Dysfunction Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Sexual Dysfunction Drugs Manufacturing Base Distribution, Product Type
4.3.1 Global Sexual Dysfunction Drugs Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Sexual Dysfunction Drugs Product Type
4.3.3 Date of International Manufacturers Enter into Sexual Dysfunction Drugs Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Sexual Dysfunction Drugs Market Size by Company
4.5.1 Top Sexual Dysfunction Drugs Players in United States, Ranked by Revenue (2021)
4.5.2 United States Sexual Dysfunction Drugs Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Sexual Dysfunction Drugs Sales by Players (2020, 2021 & 2022)
5 Global Sexual Dysfunction Drugs Market Size by Region
5.1 Global Sexual Dysfunction Drugs Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Sexual Dysfunction Drugs Market Size in Volume by Region (2017-2028)
5.2.1 Global Sexual Dysfunction Drugs Sales in Volume by Region: 2017-2022
5.2.2 Global Sexual Dysfunction Drugs Sales in Volume Forecast by Region (2023-2028)
5.3 Global Sexual Dysfunction Drugs Market Size in Value by Region (2017-2028)
5.3.1 Global Sexual Dysfunction Drugs Sales in Value by Region: 2017-2022
5.3.2 Global Sexual Dysfunction Drugs Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Sexual Dysfunction Drugs Market Size YoY Growth 2017-2028
6.1.2 North America Sexual Dysfunction Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Sexual Dysfunction Drugs Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Sexual Dysfunction Drugs Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 China Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.3 Europe
6.3.1 Europe Sexual Dysfunction Drugs Market Size YoY Growth 2017-2028
6.3.2 Europe Sexual Dysfunction Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Sexual Dysfunction Drugs Market Size YoY Growth 2017-2028
6.4.2 Latin America Sexual Dysfunction Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Sexual Dysfunction Drugs Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Sexual Dysfunction Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Pfizer
7.1.1 Pfizer Corporation Information
7.1.2 Pfizer Description and Business Overview
7.1.3 Pfizer Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Pfizer Sexual Dysfunction Drugs Products Offered
7.1.5 Pfizer Recent Development
7.2 GlaxoSmithKline
7.2.1 GlaxoSmithKline Corporation Information
7.2.2 GlaxoSmithKline Description and Business Overview
7.2.3 GlaxoSmithKline Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2017-2022)
7.2.4 GlaxoSmithKline Sexual Dysfunction Drugs Products Offered
7.2.5 GlaxoSmithKline Recent Development
7.3 Merck
7.3.1 Merck Corporation Information
7.3.2 Merck Description and Business Overview
7.3.3 Merck Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Merck Sexual Dysfunction Drugs Products Offered
7.3.5 Merck Recent Development
7.4 Eli Lilly
7.4.1 Eli Lilly Corporation Information
7.4.2 Eli Lilly Description and Business Overview
7.4.3 Eli Lilly Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Eli Lilly Sexual Dysfunction Drugs Products Offered
7.4.5 Eli Lilly Recent Development
7.5 AbbVie
7.5.1 AbbVie Corporation Information
7.5.2 AbbVie Description and Business Overview
7.5.3 AbbVie Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2017-2022)
7.5.4 AbbVie Sexual Dysfunction Drugs Products Offered
7.5.5 AbbVie Recent Development
7.6 Bayer
7.6.1 Bayer Corporation Information
7.6.2 Bayer Description and Business Overview
7.6.3 Bayer Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Bayer Sexual Dysfunction Drugs Products Offered
7.6.5 Bayer Recent Development
7.7 Teva Pharmaceutical Industries
7.7.1 Teva Pharmaceutical Industries Corporation Information
7.7.2 Teva Pharmaceutical Industries Description and Business Overview
7.7.3 Teva Pharmaceutical Industries Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Teva Pharmaceutical Industries Sexual Dysfunction Drugs Products Offered
7.7.5 Teva Pharmaceutical Industries Recent Development
7.8 Takeda
7.8.1 Takeda Corporation Information
7.8.2 Takeda Description and Business Overview
7.8.3 Takeda Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Takeda Sexual Dysfunction Drugs Products Offered
7.8.5 Takeda Recent Development
7.9 Apricus Biosciences
7.9.1 Apricus Biosciences Corporation Information
7.9.2 Apricus Biosciences Description and Business Overview
7.9.3 Apricus Biosciences Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Apricus Biosciences Sexual Dysfunction Drugs Products Offered
7.9.5 Apricus Biosciences Recent Development
7.10 Emotional Brain
7.10.1 Emotional Brain Corporation Information
7.10.2 Emotional Brain Description and Business Overview
7.10.3 Emotional Brain Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2017-2022)
7.10.4 Emotional Brain Sexual Dysfunction Drugs Products Offered
7.10.5 Emotional Brain Recent Development
7.11 Ivix LLX
7.11.1 Ivix LLX Corporation Information
7.11.2 Ivix LLX Description and Business Overview
7.11.3 Ivix LLX Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2017-2022)
7.11.4 Ivix LLX Sexual Dysfunction Drugs Products Offered
7.11.5 Ivix LLX Recent Development
7.12 Leadiant Biosciences
7.12.1 Leadiant Biosciences Corporation Information
7.12.2 Leadiant Biosciences Description and Business Overview
7.12.3 Leadiant Biosciences Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2017-2022)
7.12.4 Leadiant Biosciences Products Offered
7.12.5 Leadiant Biosciences Recent Development
7.13 NexMed
7.13.1 NexMed Corporation Information
7.13.2 NexMed Description and Business Overview
7.13.3 NexMed Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2017-2022)
7.13.4 NexMed Products Offered
7.13.5 NexMed Recent Development
7.14 S1 Biopharma
7.14.1 S1 Biopharma Corporation Information
7.14.2 S1 Biopharma Description and Business Overview
7.14.3 S1 Biopharma Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2017-2022)
7.14.4 S1 Biopharma Products Offered
7.14.5 S1 Biopharma Recent Development
7.15 Vietstar Biomedical Research
7.15.1 Vietstar Biomedical Research Corporation Information
7.15.2 Vietstar Biomedical Research Description and Business Overview
7.15.3 Vietstar Biomedical Research Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2017-2022)
7.15.4 Vietstar Biomedical Research Products Offered
7.15.5 Vietstar Biomedical Research Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Sexual Dysfunction Drugs Industry Chain Analysis
8.2 Sexual Dysfunction Drugs Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Sexual Dysfunction Drugs Distributors
8.3 Sexual Dysfunction Drugs Production Mode & Process
8.4 Sexual Dysfunction Drugs Sales and Marketing
8.4.1 Sexual Dysfunction Drugs Sales Channels
8.4.2 Sexual Dysfunction Drugs Distributors
8.5 Sexual Dysfunction Drugs Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Sexual Dysfunction Drugs CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Sexual Dysfunction Drugs Market Trends
Table 3. Sexual Dysfunction Drugs Market Drivers
Table 4. Sexual Dysfunction Drugs Market Challenges
Table 5. Sexual Dysfunction Drugs Market Restraints
Table 6. Global Sexual Dysfunction Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Sexual Dysfunction Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Sexual Dysfunction Drugs Sales by User: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Sexual Dysfunction Drugs Sales by User: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Sexual Dysfunction Drugs Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Sexual Dysfunction Drugs Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Sexual Dysfunction Drugs Revenue Share by Manufacturer, 2017-2022
Table 13. Global Sexual Dysfunction Drugs Sales by Manufacturer, (K Pcs), 2017-2022
Table 14. Global Sexual Dysfunction Drugs Sales Share by Manufacturer, 2017-2022
Table 15. Global Sexual Dysfunction Drugs Price by Manufacturer (2017-2022) & (USD/Pcs)
Table 16. Global Sexual Dysfunction Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Sexual Dysfunction Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sexual Dysfunction Drugs as of 2021)
Table 18. Top Players of Sexual Dysfunction Drugs in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Sexual Dysfunction Drugs Product Type
Table 20. Date of International Manufacturers Enter into Sexual Dysfunction Drugs Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Sexual Dysfunction Drugs Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Sexual Dysfunction Drugs Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Sexual Dysfunction Drugs Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Sexual Dysfunction Drugs Sales by Players, (K Pcs), 2020, 2021 & 2022
Table 26. United States Sexual Dysfunction Drugs Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Sexual Dysfunction Drugs Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Sexual Dysfunction Drugs Sales in Volume by Region (2017-2022) & (K Pcs)
Table 29. Global Sexual Dysfunction Drugs Sales in Volume Forecast by Region (2023-2028) & (K Pcs)
Table 30. Global Sexual Dysfunction Drugs Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Sexual Dysfunction Drugs Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Sexual Dysfunction Drugs Sales in Volume by Country (2017-2028) & (K Pcs)
Table 33. North America Sexual Dysfunction Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Sexual Dysfunction Drugs Sales in Volume by Region (2017-2028) & (K Pcs)
Table 35. Asia Pacific Sexual Dysfunction Drugs Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Sexual Dysfunction Drugs Sales in Volume by Country (2017-2028) & (K Pcs)
Table 37. Europe Sexual Dysfunction Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Sexual Dysfunction Drugs Sales in Volume by Country (2017-2028) & (K Pcs)
Table 39. Latin Americaa Sexual Dysfunction Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Sexual Dysfunction Drugs Sales in Volume by Country (2017-2028) & (K Pcs)
Table 41. Middle East and Africa Sexual Dysfunction Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. Pfizer Corporation Information
Table 43. Pfizer Description and Business Overview
Table 44. Pfizer Sexual Dysfunction Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 45. Pfizer Sexual Dysfunction Drugs Product
Table 46. Pfizer Recent Development
Table 47. GlaxoSmithKline Corporation Information
Table 48. GlaxoSmithKline Description and Business Overview
Table 49. GlaxoSmithKline Sexual Dysfunction Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 50. GlaxoSmithKline Product
Table 51. GlaxoSmithKline Recent Development
Table 52. Merck Corporation Information
Table 53. Merck Description and Business Overview
Table 54. Merck Sexual Dysfunction Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 55. Merck Product
Table 56. Merck Recent Development
Table 57. Eli Lilly Corporation Information
Table 58. Eli Lilly Description and Business Overview
Table 59. Eli Lilly Sexual Dysfunction Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 60. Eli Lilly Product
Table 61. Eli Lilly Recent Development
Table 62. AbbVie Corporation Information
Table 63. AbbVie Description and Business Overview
Table 64. AbbVie Sexual Dysfunction Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 65. AbbVie Product
Table 66. AbbVie Recent Development
Table 67. Bayer Corporation Information
Table 68. Bayer Description and Business Overview
Table 69. Bayer Sexual Dysfunction Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 70. Bayer Product
Table 71. Bayer Recent Development
Table 72. Teva Pharmaceutical Industries Corporation Information
Table 73. Teva Pharmaceutical Industries Description and Business Overview
Table 74. Teva Pharmaceutical Industries Sexual Dysfunction Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 75. Teva Pharmaceutical Industries Product
Table 76. Teva Pharmaceutical Industries Recent Development
Table 77. Takeda Corporation Information
Table 78. Takeda Description and Business Overview
Table 79. Takeda Sexual Dysfunction Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 80. Takeda Product
Table 81. Takeda Recent Development
Table 82. Apricus Biosciences Corporation Information
Table 83. Apricus Biosciences Description and Business Overview
Table 84. Apricus Biosciences Sexual Dysfunction Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 85. Apricus Biosciences Product
Table 86. Apricus Biosciences Recent Development
Table 87. Emotional Brain Corporation Information
Table 88. Emotional Brain Description and Business Overview
Table 89. Emotional Brain Sexual Dysfunction Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 90. Emotional Brain Product
Table 91. Emotional Brain Recent Development
Table 92. Ivix LLX Corporation Information
Table 93. Ivix LLX Description and Business Overview
Table 94. Ivix LLX Sexual Dysfunction Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 95. Ivix LLX Product
Table 96. Ivix LLX Recent Development
Table 97. Leadiant Biosciences Corporation Information
Table 98. Leadiant Biosciences Description and Business Overview
Table 99. Leadiant Biosciences Sexual Dysfunction Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 100. Leadiant Biosciences Product
Table 101. Leadiant Biosciences Recent Development
Table 102. NexMed Corporation Information
Table 103. NexMed Description and Business Overview
Table 104. NexMed Sexual Dysfunction Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 105. NexMed Product
Table 106. NexMed Recent Development
Table 107. S1 Biopharma Corporation Information
Table 108. S1 Biopharma Description and Business Overview
Table 109. S1 Biopharma Sexual Dysfunction Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 110. S1 Biopharma Product
Table 111. S1 Biopharma Recent Development
Table 112. Vietstar Biomedical Research Corporation Information
Table 113. Vietstar Biomedical Research Description and Business Overview
Table 114. Vietstar Biomedical Research Sexual Dysfunction Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 115. Vietstar Biomedical Research Product
Table 116. Vietstar Biomedical Research Recent Development
Table 117. Key Raw Materials Lists
Table 118. Raw Materials Key Suppliers Lists
Table 119. Sexual Dysfunction Drugs Customers List
Table 120. Sexual Dysfunction Drugs Distributors List
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Sexual Dysfunction Drugs Product Picture
Figure 2. Global Sexual Dysfunction Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Sexual Dysfunction Drugs Market Size 2017-2028 (US$ Million)
Figure 4. Global Sexual Dysfunction Drugs Sales 2017-2028 (K Pcs)
Figure 5. United States Sexual Dysfunction Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Sexual Dysfunction Drugs Market Size 2017-2028 (US$ Million)
Figure 7. United States Sexual Dysfunction Drugs Sales 2017-2028 (K Pcs)
Figure 8. United States Sexual Dysfunction Drugs Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Sexual Dysfunction Drugs Market Share in Global, in Volume (K Pcs) 2017-2028
Figure 10. Sexual Dysfunction Drugs Report Years Considered
Figure 11. Product Picture of Oral Therapy
Figure 12. Product Picture of Intracavernosal Therapy
Figure 13. Product Picture of Hormonal Therapy
Figure 14. Product Picture of Transurethral Therapy
Figure 15. Global Sexual Dysfunction Drugs Market Share by Type in 2022 & 2028
Figure 16. Global Sexual Dysfunction Drugs Sales in Value by Type (2017-2028) & (US$ Million)
Figure 17. Global Sexual Dysfunction Drugs Sales Market Share in Value by Type (2017-2028)
Figure 18. Global Sexual Dysfunction Drugs Sales by Type (2017-2028) & (K Pcs)
Figure 19. Global Sexual Dysfunction Drugs Sales Market Share in Volume by Type (2017-2028)
Figure 20. Global Sexual Dysfunction Drugs Price by Type (2017-2028) & (USD/Pcs)
Figure 21. United States Sexual Dysfunction Drugs Market Share by Type in 2022 & 2028
Figure 22. United States Sexual Dysfunction Drugs Sales in Value by Type (2017-2028) & (US$ Million)
Figure 23. United States Sexual Dysfunction Drugs Sales Market Share in Value by Type (2017-2028)
Figure 24. United States Sexual Dysfunction Drugs Sales by Type (2017-2028) & (K Pcs)
Figure 25. United States Sexual Dysfunction Drugs Sales Market Share in Volume by Type (2017-2028)
Figure 26. United States Sexual Dysfunction Drugs Price by Type (2017-2028) & (USD/Pcs)
Figure 27. Product Picture of Male
Figure 28. Product Picture of Female
Figure 29. Global Sexual Dysfunction Drugs Market Share by User in 2022 & 2028
Figure 30. Global Sexual Dysfunction Drugs Sales in Value by User (2017-2028) & (US$ Million)
Figure 31. Global Sexual Dysfunction Drugs Sales Market Share in Value by User (2017-2028)
Figure 32. Global Sexual Dysfunction Drugs Sales by User (2017-2028) & (K Pcs)
Figure 33. Global Sexual Dysfunction Drugs Sales Market Share in Volume by User (2017-2028)
Figure 34. Global Sexual Dysfunction Drugs Price by User (2017-2028) & (USD/Pcs)
Figure 35. United States Sexual Dysfunction Drugs Market Share by User in 2022 & 2028
Figure 36. United States Sexual Dysfunction Drugs Sales in Value by User (2017-2028) & (US$ Million)
Figure 37. United States Sexual Dysfunction Drugs Sales Market Share in Value by User (2017-2028)
Figure 38. United States Sexual Dysfunction Drugs Sales by User (2017-2028) & (K Pcs)
Figure 39. United States Sexual Dysfunction Drugs Sales Market Share in Volume by User (2017-2028)
Figure 40. United States Sexual Dysfunction Drugs Price by User (2017-2028) & (USD/Pcs)
Figure 41. North America Sexual Dysfunction Drugs Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 42. North America Sexual Dysfunction Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 43. U.S. Sexual Dysfunction Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 44. Canada Sexual Dysfunction Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 45. Europe Sexual Dysfunction Drugs Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 46. Europe Sexual Dysfunction Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 47. Germany Sexual Dysfunction Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 48. France Sexual Dysfunction Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 49. U.K. Sexual Dysfunction Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 50. Italy Sexual Dysfunction Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 51. Russia Sexual Dysfunction Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 52. Asia-Pacific Sexual Dysfunction Drugs Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 53. Asia-Pacific Sexual Dysfunction Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 54. China Sexual Dysfunction Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 55. Japan Sexual Dysfunction Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 56. South Korea Sexual Dysfunction Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 57. India Sexual Dysfunction Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. Australia Sexual Dysfunction Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. China Taiwan Sexual Dysfunction Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. Indonesia Sexual Dysfunction Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. Thailand Sexual Dysfunction Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Malaysia Sexual Dysfunction Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 63. Latin America Sexual Dysfunction Drugs Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 64. Latin America Sexual Dysfunction Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 65. Mexico Sexual Dysfunction Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 66. Brazil Sexual Dysfunction Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 67. Argentina Sexual Dysfunction Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 68. Middle East & Africa Sexual Dysfunction Drugs Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 69. Middle East & Africa Sexual Dysfunction Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 70. Turkey Sexual Dysfunction Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 71. Saudi Arabia Sexual Dysfunction Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 72. UAE Sexual Dysfunction Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 73. Sexual Dysfunction Drugs Value Chain
Figure 74. Sexual Dysfunction Drugs Production Process
Figure 75. Channels of Distribution
Figure 76. Distributors Profiles
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed
